Orthodox Street Overview

  • 128k sq. ft.
    • Main Building: 115k sq. ft.
    • QC Building: 13k sq. ft.
  • Adare-owned facility​
  • R&D Manufacturing and Labs
  • QC Lab
  • Kommerzielle Fertigung
    • Capabilities include: blending, granulation, drying, encapsulation, and compression
    • Current Manufacturing Capacity: 3Bn tablets and capsules
  • Manufacturing License for DEA Schedules II, 2N, III, 3N, IV, L1
  • High Potency Manufacturing Suite​
  • GMP Manufacturing and Lab Facilities
    • 12 commercial tablet presses, 5 capsule fillers​
    • Clinical trial manufacturing suites (bench & pilot)​
    • 2 Analytical laboratories housing over 100 instruments​
  • Controlled Drug Storage (CRX) Cage & Vault​
  • Last FDA Inspections – (1) GMP in 2019 with 1 Observation and (2) PAI in 2021 with no observations